napabucasin

Another effort on pancreatic cancer flops, as Boston Biomedical cans phase 3 combo test
Fierce Biotech
Tue, 07/2/19 - 10:30 am
Boston Biomedical
clinical trials
pancreatic cancer
napabucasin